African Americans more likely to exhibit negative perceptions of cancer-related clinical trials
the ONA take:
According to new findings that will be presented at the 2015 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, researchers from Fox Chase Cancer Center and Temple University in Philadelphia, Pennsylvania, have found that African Americans are more likely to display negative perceptions of participating in cancer-related clinical trials.
For the study, researchers identified 41 African Americans with an average age of 60 years. Of those, 54% had no enrolled in a clinical trial within the past 9 months.
Researchers found that non-participants believed that a clinical trial would make them sicker, that important information would be withheld from them, and that no one discussed clinical trial participation with them.
Those who participated in clinical trials felt their doctor had provided enough information in order to make an informed decisions about clinical trial participation and that trials offered the best possible treatment for their disease.
The findings suggest that African American patients with cancer should received detailed information regarding clinical trial participation and their treatment options.
African Americans are more likely to display negative perceptions of participating in cancer-related clinical trials.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
- Urine Drug Testing Policy Can Assist Opioid Treatment Decisions
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|